Literature DB >> 15122243

Arming the osteoclast.

Roland Baron.   

Abstract

Mesh：

Year:  2004        PMID： 15122243     DOI： 10.1038/nm0504-458

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  21 in total

1.  Cytoskeletal dysfunction dominates in DAP12-deficient osteoclasts.

Authors:  Wei Zou; Tingting Zhu; Clarissa S Craft; Thomas J Broekelmann; Robert P Mecham; Steven L Teitelbaum
Journal:  J Cell Sci       Date:  2010-09-01       Impact factor: 5.285

2.  Identification of novel RANK polymorphisms and their putative association with low BMD among postmenopausal women.

Authors:  J-M Koh; B L Park; D J Kim; G S Kim; H S Cheong; T-H Kim; J-M Hong; H-I Shin; E K Park; S-Y Kim; H D Shin
Journal:  Osteoporos Int       Date:  2006-11-18       Impact factor: 4.507

3.  Glucocorticoid excess in mice results in early activation of osteoclastogenesis and adipogenesis and prolonged suppression of osteogenesis: a longitudinal study of gene expression in bone tissue from glucocorticoid-treated mice.

Authors:  Wei Yao; Zhiqiang Cheng; Cheryl Busse; Aaron Pham; Mary C Nakamura; Nancy E Lane
Journal:  Arthritis Rheum       Date:  2008-06

Review 4.  Osteoprotegerin as a potential therapy for osteoporosis.

Authors:  Neveen A T Hamdy
Journal:  Curr Osteoporos Rep       Date:  2005-12       Impact factor: 5.096

5.  Defective entry into mitosis 1 (Dim1) negatively regulates osteoclastogenesis by inhibiting the expression of nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 1 (NFATc1).

Authors:  Daniel An; Kyunghwan Kim; Wange Lu
Journal:  J Biol Chem       Date:  2014-07-14       Impact factor: 5.157

6.  JMJD5, a Jumonji C (JmjC) domain-containing protein, negatively regulates osteoclastogenesis by facilitating NFATc1 protein degradation.

Authors:  Min-Young Youn; Atsushi Yokoyama; Sally Fujiyama-Nakamura; Fumiaki Ohtake; Ken-ichi Minehata; Hisataka Yasuda; Takeshi Suzuki; Shigeaki Kato; Yuuki Imai
Journal:  J Biol Chem       Date:  2012-02-28       Impact factor: 5.157

Review 7.  Mechanistic insight into osteoclast differentiation in osteoimmunology.

Authors:  Hiroshi Takayanagi
Journal:  J Mol Med (Berl)       Date:  2005-01-26       Impact factor: 4.599

8.  Estrogen action on bone marrow osteoclast lineage cells of postmenopausal women in vivo.

Authors:  J A Clowes; G Z Eghbali-Fatourechi; L McCready; M J Oursler; S Khosla; B L Riggs
Journal:  Osteoporos Int       Date:  2008-09-04       Impact factor: 4.507

Review 9.  Osteoprotegerin as a potential therapy for osteoporosis.

Authors:  Neveen A T Hamdy
Journal:  Curr Rheumatol Rep       Date:  2006-02       Impact factor: 4.592

10.  In vivo genome-wide expression study on human circulating B cells suggests a novel ESR1 and MAPK3 network for postmenopausal osteoporosis.

Authors:  Peng Xiao; Yuan Chen; Hui Jiang; Yao-Zhong Liu; Feng Pan; Tie-Lin Yang; Zi-Hui Tang; Jennifer A Larsen; Joan M Lappe; Robert R Recker; Hong-Wen Deng
Journal:  J Bone Miner Res       Date:  2008-05       Impact factor: 6.741
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.